1. Hepatocellular carcinoma - imaging methods and imaging guided therapy
- Author
-
Duras Petr, Fínek Jindřich, Ferdová Eva, Ferda Jiří, and Mírka Hynek
- Subjects
medicine.medical_specialty ,Carcinoma, Hepatocellular ,Radiofrequency ablation ,Computed tomography ,Multimodal Imaging ,law.invention ,law ,medicine ,Animals ,Humans ,medicine.diagnostic_test ,business.industry ,Ultrasound ,Liver Neoplasms ,Magnetic resonance imaging ,Interventional radiology ,medicine.disease ,digestive system diseases ,Oncology ,Surgery, Computer-Assisted ,Positron emission tomography ,Clinical question ,Hepatocellular carcinoma ,Catheter Ablation ,Radiology ,business - Abstract
The imaging modality choice depends on the clinical question in hepatocellular carcinoma (HCC); when HCC is suspected, then ultrasound serves as imaging at the first line, followed by computed tomography. When specialized differential dia-gnosis or bio-logical behaviour of HCC is a clinical issue, magnetic resonance imaging with a use of hepatospecific contrast agent or hybrid imaging using positron emission tomography and computed tomography or positron emission tomography and magnetic resonance imaging with the application of 18F-fluorodeoxglucose or 18F-fluorocholine are exploited. In the therapy of HCC, it is possible to use locally destructive methods of interventional radiology, especially radiofrequency ablation or transarterial chemoembolization, or radioembolization, as the case may be.
- Published
- 2020